(19)

(11)

EP 2 618 820 A2

(12)

(88) Date of publication A3: 18.05.2012 (43) Date of publication: 31.07.2013 Bulletin 2013/31 (21) Application number: 11764653.9 (22) Date of filing: 23.09.2011

(51) International Patent Classification (IPC):  A61K 9/20(2006.01) A61K 31/485(2006.01) A61K 9/50(2006.01) A61P 25/04(2006.01) (86) International application number: PCT/US2011/053132 (87) International publication number: WO 2012/040651 (29.03.2012 Gazette 2012/13)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (30) Priority: 24.09.2010 US 386227 P 09.02.2011 US 201113024319 (71) Applicant: Qrxpharma Limited North Sydney, NSW 2060 (AU)	(72) Inventors: RUDNIC, Edward, M. Bedminster, NJ 07921 (US) VACHON, Michael Bedminster, NJ 07921 (US) PACE, Gary, W. Bedminster, NJ 07921 (US) BERRY, Joseph Bedminster, NJ 07921 (US) IGLESIA, Felix, De La Bedminster, NJ 07921 (US) (74) Representative: Alcock, David  D Young & Co LLP 120 Holborn London EC1N 2DY London EC1N 2DY (GB)